# Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Study · id `cardio:ct-nct05498740` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05498740](<https://clinicaltrials.gov/study/NCT05498740>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05498740

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05498740. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-04 (actual); primary completion 2022-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05498740, source copy `cardio:ctgov-nct05498740-2022-08-12`, retrieved 2026-10-31)
- Started: 2022-05-04 (actual) (ClinicalTrials.gov record NCT05498740, source copy `cardio:ctgov-nct05498740-2022-08-12`, retrieved 2026-10-31)
- Primary completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT05498740, source copy `cardio:ctgov-nct05498740-2022-08-12`, retrieved 2026-10-31)
- Completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT05498740, source copy `cardio:ctgov-nct05498740-2022-08-12`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT05498740, source copy `cardio:ctgov-nct05498740-2022-08-12`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05498740-2022-08-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
- Acronym: UltraFuture I
- Condition: Peripheral Arterial Disease (PAD)
- Intervention (Device): Drug eluting Balloon
- Lead sponsor: Zhejiang Zylox Medical Device Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Zhejiang Zylox Medical Device Co., Ltd. (`cardio:org-zhejiang-zylox-medical-device-co-ltd`)

## Provenance

Content hash: e650466ea0a93c159f011ba385b807bb85e36b14c4c0e2c3289252fd22ea1d9d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
